Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

NCT02354352 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT02354352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02354352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Lead sponsor
Ohio State University
Phase
Phase 3
Overall status
Completed
Start date
March 20, 2015
Completion date
May 31, 2018
Enrollment
52 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy